Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc. presents a promising investment opportunity as it trades around $4 per share, with significant upside potential contingent on favorable multi-dose data outcomes. The company has achieved a remarkable 53.7% splicing correction in its therapeutic candidate, PGN-EDO51, which exceeds the performance of competitors, indicating robust efficacy in the treatment of neuromuscular diseases. The Enhanced Delivery Oligonucleotide platform, coupled with a diversified pipeline that includes PGN-EDODM1 and others, positions PepGen favorably in the biotechnology sector, reflecting its potential for substantial advancements in muscle performance with ongoing clinical trials.

Bears say

PepGen Inc.'s stock outlook is negatively affected by a $1 decrease in its target price to $8 per share, reflecting a concerning valuation despite best-in-class data and a favorable safety profile for its DM1 treatment. The company faces heightened risks related to its commercial execution and the potential inability to meet or exceed market expectations, which could adversely impact share performance. Additionally, challenges in accessing capital markets pose significant threats, potentially leading to delays or termination of crucial development programs.

PepGen Inc (PEPG) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 4 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.